This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Effect of cabazitaxel on the growth of human castration-refractory prostate cancer cells in vitro compared to docetaxel and on the anti-tumor properties of the angio-inhibitor PEDF in vivo., Journal of Clinical Oncology, March 2015, American Society of Clinical Oncology (ASCO),
DOI: 10.1200/jco.2015.33.7_suppl.205.
You can read the full text:
The following have contributed to this page
